Primemd Inc. (PRMD)
OTCMKTS · Delayed Price · Currency is USD
0.0700
+0.0696 (17,400.00%)
At close: Aug 12, 2026
Primemd Revenue
Primemd had revenue of $10.47K in the quarter ending December 31, 2008, a decrease of -57.82%. This brings the company's revenue in the last twelve months to $69.98K, up 16.61% year-over-year. In the fiscal year ending March 31, 2008, Primemd had annual revenue of $67.80K with 37.96% growth.
Revenue (ttm)
69.98K
Revenue Growth
+16.61%
P/S Ratio
23.73
Revenue / Employee
69.98K
Employees
1
Market Cap
1.66M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2008 | 67.80K | 18.66K | 37.96% |
| Mar 31, 2007 | 49.15K | -3.49K | -6.64% |
| Mar 31, 2006 | 52.64K | 13.51K | 34.53% |
| Mar 31, 2005 | 39.13K | -18.80K | -32.45% |
| Mar 31, 2004 | 57.93K | -314.00 | -0.54% |
| Mar 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 1999 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aesthetic Medical International Holdings Group | 103.35M |
| Regional Health Properties | 80.80M |
| Veltex | 70.13M |
| Ethema Health | 18.76M |
| Cardiff Lexington | 10.21M |
| Yuka Group | 7.84M |
| Stem Cell Authority | 3.33M |
| Xcelerate | 2.70M |